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Abstract
Platelet adhesion to the brain microvasculature has been associated with cerebral malaria (CM) in humans, suggesting that
platelets play a role in the pathogenesis of this syndrome. In vitro co-cultures have shown that platelets can act as a bridge
between Plasmodium falciparum-infected red blood cells (pRBC) and human brain microvascular endothelial cells (HBEC)
and potentiate HBEC apoptosis. Using cDNA microarray technology, we analyzed transcriptional changes of HBEC in
response to platelets in the presence or the absence of tumor necrosis factor (TNF) and pRBC, which have been reported to
alter gene expression in endothelial cells. Using a rigorous statistical approach with multiple test corrections, we showed a
significant effect of platelets on gene expression in HBEC. We also detected a strong effect of TNF, whereas there was no
transcriptional change induced specifically by pRBC. Nevertheless, a global ANOVA and a two-way ANOVA suggested that
pRBC acted in interaction with platelets and TNF to alter gene expression in HBEC. The expression of selected genes was
validated by RT-qPCR. The analysis of gene functional annotation indicated that platelets induce the expression of genes
involved in inflammation and apoptosis, such as genes involved in chemokine-, TREM1-, cytokine-, IL10-, TGFb-, death-
receptor-, and apoptosis-signaling. Overall, our results support the hypothesis that platelets play a pathogenic role in CM.
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Introduction
Malaria remains a major problem of public health in tropical
developing countries worldwide. Close to 230 million people
(World Health Organization) are infected annually with Plasmo-
dium falciparum. About 1–2% out of clinical attacks of malaria are
complicated by severe manifestations leading to death. The major
syndromes of severe malaria are severe anaemia, severe respira-
tory distress, and cerebral malaria (CM) [1]. Severe malaria
predominantly affects children under 5 years of age, non-immune
adults, and pregnant women. More generally, the outcome of
infection depends on numerous factors, including host and parasite
genetics, host age, rates of infection, and host immune status.
CM is a complex neurological syndrome, which accounts for a
large proportion of deaths due to malaria. CM is characterized by
the sequestration of P. falciparum-infected red blood cells (pRBC),
leukocytes, and platelets in brain microvessels. It has been
proposed that this accumulation of pRBC interferes with
microcirculation, and leads to ischemia [2]. In addition, many
observations provide evidence that leukocytes and inflammatory
cytokines, such as tumor necrosis factor (TNF), are involved in
malaria pathogenesis [2,3]. TNF produced by monocytes activates
endothelial cells, thereby increasing the expression of cell adhesion
molecules, such as P-selectin, ICAM-1 and VCAM-1. Increased
expression of endothelial cell adhesion molecules contributes to
enhanced pRBC sequestration, leukocyte and platelets adhesion.
There is a growing body of evidence that platelets (PL) are
involved in CM pathogenesis: (i) thrombocytopenia is marked
during P. falciparum and experimental CM; (ii) PL adhesion to the
microvessels has been associated with CM in humans [4], and has
been shown to be involved in mouse CM pathogenesis [4,5]; (iii) in
vitro co-cultures showed that PL act as a bridge between pRBC and
TNF-stimulated endothelium, and contribute to brain endothelial
alterations [6,7].
These studies prompted us to analyze gene expression in
endothelial cells co-incubated with PL in an in vitro model of CM.
Microarray analyses showed that pro-inflammatory cytokines,
including TNF, induce distinct gene expression programs in
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endothelial cell type should be carefully chosen for an in vitro
model of CM. Some studies have investigated the direct effect of
pRBC alone on the human umbilical vein endothelial cell
(HUVEC) transcriptome, and revealed changes in the expression
of genes involved in tight junction, inflammatory response, and
apoptosis [10,11,12], whereas co-cultures with human lung
microvascular endothelial cells (HLEC) showed that pRBC
induces apoptosis through a caspase-dependent pathway [13].
Recently, a genome wide transcriptional profiling of human brain
microvascular endothelial cells (HBEC) after exposure with pRBC
revealed up-regulated transcripts involved in the immune res-
fponse, apoptosis, and NF-kB activation cascade [14]. Nonethe-
less, the influence of PL on endothelial cell gene expression has not
been evaluated in those models. We therefore investigated
transcriptional changes in HBEC in a tri-partite co-culture model
including TNF, pRBC, and PL. This model is a well established in
vitro model of CM, which has been validated for a number of
interactions, as recently reviewed [15]. Here, we report that PL
induced transcriptional changes in HBEC related to canonical
pathways involved in inflammation or apoptosis.
Materials and Methods
Human brain endothelial cells
HBEC-5i were derived by Dorovonis-Zis and colleagues from
small fragments of human cortex obtained from patients who died
of various causes, devoid of any pathological abnormalities [16].
These cells were immortalized and characterized as described
elsewhere [7]. HBEC-5i were grown to confluence in DMEM/F12
medium containing 15 mmol/L HEPES and L-glutamine pH 7.4
(Gibco Life Technologies, Carlsbad USA) supplemented with 10%
(v/v) of fetal bovine serum. Conservation of the phenotype of this
cell line was checked over passages and cell line was tested negative
for mycoplasma contamination every 5 passages.
Platelets
Venous blood was obtained by venipuncture from one healthy
volunteer and anticoagulated with 3.2 g/L buffered sodium
citrate. The volunteer had not taken any drugs for at least 1
month. The healthy volunteer gave a written informed consent.
Experiments were performed after clearance from human ethics
committee of the University of Sydney, which approved the study.
Platelet-rich plasma was prepared by centrifugation at 200 g for
15 minutes at room temperature then PL were pelleted by
centrifugation of the PL-rich plasma for 6 minutes at 2000 g and
washed in HEPES buffer warmed at 37uC (0.137 M NaCl,
2.68 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES,
0.1%glucose, pH=6.8). PL were then adjusted to 1.10
8/mL. PL
functions were tested by agonist-induced platelet aggregation and
PL activation was assessed by flow cytometric measurement of P-
selectin in PL-rich plasma and washed PL suspension. PL of the
volunteer had a normal reactivity compared to a reference
population of 35 healthy controls, and washing steps did not alter
either platelet reactivity or activation state.
Parasites
The IPPAM strain of P. falciparum (gift from C. Behr, Institut
Pasteur, Paris, France) was obtained by panning on endothelial
cells expressing either GPIV (CD36) or ICAM-1 using the method
described by Fried and Duffy [17]. Parasites were maintained in
continuous culture at 2% hematocrit using type O+ human red
blood cells (RBC) as described elsewhere [18]. Uninfected normal
red blood cells (NRBC) used as controls were cultured the same
way for at least 2 weeks before experiments. Late trophozoite-stage
pRBC preparations were enriched to 80 to 85% by gelatin
flotation with Plasmion (Fresenius Kabi France, Couvier France)
as described elsewhere [19]. NRBC or pRBC were adjusted to
2610
7/mL in the co-culture medium composed of RPMI 1640
with the pH adjusted to 6.8 before use.
Human brain endothelial cells-platelets-parasitized red
blood cells co-cultures
HBEC were grown to confluence in 6-well tissue culture plates
and were either left unstimulated or incubated overnight with
10 ng/mL recombinant TNF (PeproTech, London UK). HBEC
were then washed with PBS and incubated with PL, pRBC or
NRBC according to the experimental conditions with the
following sequence: HBEC were first incubated with 2610
8 PL
per well as a first step, washed three times in PBS to remove
unbound PL and 4610
7 pRBC or NRBC per well were then
added as a second step. First and second incubation steps were
carried out at 37uC for 90 min. Co-cultures without TNF, PL,
pRBC, or NRBC were also performed. Table 1 summarizes all the
experimental conditions (n=24). Each experimental condition was
done in triplicate.
RNA isolation
After co-incubation, HBEC were washed three times with PBS
and either harvested immediately (t=0 h) or further incubated for
5 h (t=5 h) and then harvested. Total RNA extraction of HBEC
was carried out after harvesting using TRIzol (Gibco Life
Technologies, Carlsbad USA) according to the manufacturer’s
instructions. RNA concentration was determined by reading the
absorbance at 260/280 nm. The quality of RNA and the absence
of any DNA contamination were checked on a 2100 Bioanalyzer
(Agilent Technologies, Santa Clara USA). Each mRNA sample
extracted from an individual sample was run on a single
microarray.
cDNA Microarray Hybridization
Hybridizations were carried out for each triplicate of the 24
conditions. All microarray procedures were done at our micro-
array facilities. Human cDNA microarray were designed and
prepared as previously described [20]. PCR amplification was
performed as previously described [21], and PCR products were
spotted onto nylon membranes (Hybond-N
+, Amersham, Phar-
macia Biotech, UK) with a GMS-427 arrayer (Affymetrix, Santa
Clara USA). 9216 clones were spotted; they corresponded to 8780
genes and 436 controls. Production, sensitivity and reproducibility
Table 1. Summary of the 24 experimental conditions
a.
- Platelets (PL)
- TNF (T) - TNF (T)
0h
b - 0 h 0h_T 0h_PL 0h_T_PL
NRBC (NR) 0h_NR 0h_T_NR 0h_NR_PL 0h_T_NR_PL
pRBC (PR) 0h_PR 0h_T_PR 0h_PR_PL 0h_T_PR_PL
5h
b - 5 h 5h_T 5h_PL 5h_T_PL
NRBC (NR) 5h_NR 5h_T_NR 5h_NR_PL 5h_T_NR_PL
pRBC (PR) 5h_PR 5h_T_PR 5h_PR_PL 5h_T_PR_PL
aLabels used on Figure 1. Each experimental condition was done in triplicate.
bTime after co-incubation.
doi:10.1371/journal.pone.0019651.t001
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array were hybridized with
33P-labelled probes, first with an
oligonucleotide sequence common to all spotted PCR products
(59TCACACAGGAAACAGCTATGAC39) called vector probe to
measure the amount of PCR products spotted onto the
microarray. Then, after stripping, microarrays were hybridized
with complex probes made from 5 mg of retrotranscribed total
RNA. Probe preparations, hybridizations and washes were carried
out as described previously [22]. Microarrays were exposed on a
radioimager during 48 h and scanned using a Fuji BAS5000
machine (Fuji, France). Hybridization signals were quantified
using BZscan 2 software [23] locally developed on the TAGC
platforms (http://tagc.univ-mrs.fr/welcome/). All data are
MIAME compliant and have been loaded into ArrayExpress
database (http://www.ebi.ac.uk/microarray-as/ae/). The Ar-
rayExpress accession number of this experiment is E-MEXP-1989.
Microarray data Analysis
BZscan first applied a criterion of spot quality to select analyzable
spots on the microarrays. 4502 genes passed through this selection
for all conditions and were analyzed. Since the hybridization signal
depends on the amount of PCR products spotted onto the
microarray, the signal obtained with the vector probe was used to
normalize the signal obtained with complex probes [24]. A specific
R library, ‘nylonmagic’ (currently under development, script
available upon request), that uses the ‘S4’ system of formal classes
and methods was used to process and normalize nylon microarray
data [25]. After loading, data obtained with vector probe and
complex probes were both corrected for neighborhood effects and
local background as described [23]. Quantile normalization was
applied to vector probe data (V) and complex probe data (C) to
correct for global intensity and dispersion. In a third step, the
correction by the vector signal was made by calculating a C/V ratio
before log transformation (base 2). The basic approach relies on the
assumptionthat the complex and vector signal intensities arerelated
by a constant factor. However, as reported by others, in many cases,
log(C/V) still depends on log(V) [24]. To correct for this bias, we
used the method proposed by Talby et al [24]. For any sample, Ck
and Vk denote the complex and vector probe signals, and k
represents the array element. The curve Mk=log(Ck/Vk) versus
log(Vk) was fitted using a robust scatter-plot smoother (lowess
regression). The normalization adjustment was M9k=M k2
s(log(Vk)), where s(log(Vk)) was the lowess fit to the M versus log(V).
In the last step, data were centered relative to the median for each
gene.
Unsupervised hierarchical clustering was used to investigate
relationships between samples and relationships between genes, and
to evaluate the effect of the different sources of variability (TNF, PL,
RBC, time-points, and replicates). It was applied to median-centred
data, using the Cluster and TreeView programs (average linkage
clustering using Euclidian distance as similarity metric).
Statistical analysis was performed using the TIGR MeV
(MultiExperiment Viewer) v4.1 software (http://www.tm4.org/
mev.html) and the GeneANOVA programs [26]. One-way
analysis of variance was applied to identify genes differentially
expressed between the treatment groups. Paired t-tests and paired
significant microarray analysis method (SAM) were used to
evaluate the influence of one particular variability factor (TNF,
PL, RBC, and time). The members of each pair differed from each
other only with respect to the factor studied. Therefore, the paired
design allowed isolating the contribution of the factor of interest.
Empirical P-values were calculated after 10000 permutations.
Moreover, we applied the adaptive false discovery rate (FDR)
procedure to control the FDR for the paired t-tests and the paired
SAM, respectively [27,28]. The FDR of a test is the expected
proportion of false positive results among the declared significant
ones. We generally used an FDR of 5%.
In addition, an ANOVA based on the microarray analysis was
used to analyze simultaneously the effect of TNF, PL, RBC, and
time on gene expression. A global ANOVA model gives an
estimation of the contribution of each factor in the total variation
of the whole data set; gene was considered a factor in this model,
and interaction terms were included [29]; no multiple test
correction was performed. Besides, a local ANOVA allows the
determination of each contribution for each gene: it gives an
estimation of the variation due to the factor studied, and the
significance of the estimate. We applied the adaptive false
discovery rate (FDR) procedure to control the FDR for the local
ANOVA [27,28]. We generally used an FDR of 5%. In addition, a
two-way ANOVA was performed to analyse for each gene the
interaction RBC-by-TNF and the interaction RBC-by-PL.
Empirical P values were calculated after permutations, and
multiple testing was controlled by using the adaptive FDR.
Figure 1. Hierarchical clustering of HBEC responses to NRBC, pRBC, TNF, and platelets. A) Hierarchical clustering of 72 samples was done
on the basis of the expression of 469 genes that were selected by using a one-way ANOVA. Each row represents a gene, and each column an
experimental sample. Red and green indicate expression levels above and below the median for each gene, respectively. Similarities in gene
expression are represented by dendogrammes of samples and genes. B) Dendogramme of samples. 24 experimental conditions and 3 samples per
condition are represented. For each condition, the presence (black) or the absence (white) of factors is specified. The factors are NRBC (2/+), pRBC
(2/+), co-culture time (0 h and 5 h), PL (2/+), and TNF (2/+).
doi:10.1371/journal.pone.0019651.g001
Table 2. Multi-way analysis of variance for HBEC gene
expression data.
Factor
Sum of
square DF
a
Mean
square F P-value
gene 849219.05 4501 188.67 274.11 ,0.00001
RBC 0.37 2 0.18 0.27 -
TNF 0.17 1 0.17 0.24 -
PL 4.37 1 4.37 6.56 0.01013
time 0.1 1 0.1 0.15 -
gene6RBC 6341.37 9002 0.7 1.02 0.0416
gene6TNF 6497.82 4501 1.44 2.1 ,0.00001
gene6PL 4644.08 4501 1.03 1.5 ,0.00001
gene6time 5355.23 4501 1.19 1.73 ,0.00001
gene6time6TNF 3250.75 4501 0.72 1.09 0.00005
gene6time6PL 3264.17 4501 0.73 1.09 0.00002
gene6TNF6PL 3219.91 4501 0.72 1.07 0.00029
gene6time6RBC6TNF 6177.54 9002 0.69 1.03 0.0214
gene6time6RBC6PL 6256.12 9002 0.69 1.04 0.0026
Residual
b 176809.89 265625 0.67 - -
Total 1070570.59 324143 3.3 - -
aDegree of freedom.
bThe residual corresponds to the variance that was not explained by the model.
doi:10.1371/journal.pone.0019651.t002
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sequence tags (ESTs) was performed using DAVID database
(http://david.abcc.ncifcrf.gov/) [30]. This program, which allows
a biological interpretation of gene clusters on the basis of gene
ontology (GO) terms and the Kyoto Encyclopaedia of Genes and
Genomes (KEGG) pathways (http://www.genome.jp/kegg/),
were used to assess whether specific biological pathways were
overrepresented among the differentially expressed genes and
within specific gene clusters. A score based on Fisher’s exact test
reflected the probability that the prevalence of a particular term
within a cluster was due to chance alone, given the prevalence of
that term in the population of all genes under study. The FDR was
used to account for multiple testing [27].
The Ingenuity Pathways Analysis (IPA) program permitted the
determination of significant networks, top functions and canonical
pathways associated with the differentially expressed genes (IPA
5.0, Ingenuity Systems Inc., USA). The IPA program searches the
Ingenuity Pathway Knowledge Base (IPKB) for interactions
(known from the literature) between the studied gene set and all
other genes contained in IPKB and generates a series of networks.
The genes selected by the IPA network analysis are called focus
genes. Fisher’s exact test was used to assign statistical significance,
and each network’s score was displayed as the 2log (P-value).
Significant networks with a score greater than 3 were selected
(P,0.001) and top functions associated with these networks are
presented. Canonical pathway analysis identified the most
significant pathways, from the IPA library of canonical pathways.
The association between the input data set and the canonical
pathway was scored as the ratio of the number of genes from the
data set that map to the pathway divided by the total number of
genes that map to the canonical pathway; their significance was
assessed by using a P-value calculated by using Fisher’s exact test.
Quantitative Real-Time PCR
RNA of HBEC used for Real-Time-quantitative Polymerase
Chain Reaction (RT-qPCR) was obtained from another co-culture
experiment. cDNAs were prepared from 2 mg of total RNA using
random hexamers pd(N)6 (GE Healthcare, UK) and M-MLV
reverse transcriptase (Invitrogen Life Technologies, Carlsbad
USA). RT-qPCR assays were performed on AB-7300 Real-Time
PCR system using SYBR PCR Master Mix (Applied Biosystems
Life Technologies, Carlsbad USA). Forward and reverse primers
used are shown in Table S1. They were designed manually to have
primers spanning exon-exon junctions to avoid the amplification
of DNA contaminant. PCR were performed using the following
conditions: 10 min at 95uC, 15 sec at 95uC and 1 min at 60uC
during 40 cycles. Melting curve analysis was performed to check
the specificity of the PCR and to verify the amplification efficiency.
Relative quantification was calculated with the 2
2DDC(t) method:
DC(t) represents the difference between the threshold cycle of the
gene of interest and the threshold cycle of the internal control gene
(ACTB). Co-cultures were incubated during 5 h, and each tested
condition was done twice.
Results
We used an unsupervised hierarchical clustering method that
grouped genes on the vertical axis and samples on the horizontal
axis, on the basis of similarity in their expression profiles. The
similarities are summarized in a dendogramme in which the
pattern and length of the branches reflect the relatedness of the
samples. The discrimination between experimental conditions was
unsatisfactory on this basis (data not shown). We assumed that the
samples were incorrectly classified because of confounding genes,
which were not differentially expressed between groups. There-
fore, we filtered the genes by using a one-way ANOVA to visualize
the effect of experimental conditions. We generated empirical P-
value for each gene, and selected the genes for which P,0.05. We
defined 469 informative genes, and we performed unsupervised
hierarchical clustering of samples on the basis of the expression of
selected genes. Figures 1A and 1B show the classification of
samples obtained.
We further performed a multi-way ANOVA over the whole data
set to estimate the contribution of each factor. Such estimates could
be performed because we used a fully crossed factorial design,
meaning that each state of one factor was found in combination
with each state of other factors (Table 1). So, there were 72
measurements for each of the 4502 genes, three per combination of
four factors (RBC, TNF, PL and time). Table 2 presents the results
of a global ANOVA over the whole data set. It shows that the major
source of variation was the gene factor, and that there was a highly
significant interactionbetween the gene factor on the one hand, and
time, TNF or PL on the other hand (P,0.0001), whereas the
interaction between the gene factor and RBC appeared to be
weaker (P=0.04). In addition, the analysis revealed a significant
interaction between gene, PL and TNF (P=0.00029). Interestingly,
RBCwas includedinhigh-orderinteraction terms, namely gene-by-
time-by-RBC-by-TNF(P=0.02),and gene-by-time-by-RBC-by-PL
(P=0.002).
Moreover, we performed an ANOVA for each gene to identify
genes showing significant variation in their expression pattern. We
assessed the effect of TNF, PL, RBC, and time on gene expression;
we did not include interaction terms at this step. Figure 2A and 2B
shows a graphical representation of the proportion of gene
expression variance due to TNF and PL and the logarithm of P-
value for each gene. Up to 90% of the variance was explained by
TNF or PL for some genes (Figure 2A and 2B), whereas up to 50%
of the variance was explained by time (Figure S1A). RBC
explained less than 20% of gene expression variance (Figure
S1B). Furthermore, we applied a FDR of 5% to account for
multiple testing. We identified 39, 143, and 109 genes, the
expression of which was significantly altered by PL (Table 3), TNF
(Table S2), and time (Table S3), respectively, whereas there was no
gene influenced by the factor RBC at this significance level.
We applied additional statistical analyses to identify genes, the
expression of which was altered by one particular factor. We used
the paired t-test and paired SAM method on the full data set
(n=4502), and applied a FDR of 5%. Paired t-tests yielded lists of
107 and 32 genes that showed a differential expression between
experimental conditions with and without TNF and PL,
respectively. Hierarchical clusterings of TNF- and PL-informative
genes yielded with the t-test are presented in Figures 3 and 4
respectively. Seventy-one genes were also differentially expressed
when comparing gene expression at 0 h and 5 h. Table 3 shows
the genes transcriptionally modified by the platelets (PL) as
determined by the three different methods. Comparison of the
methods of analysis indicates that SAM identified the largest
number of differentially expressed genes (54 genes), whereas
Figure 2. Gene expression variance analysis. Each gene was plotted as a point. The abscissa is the variation due to the factor normalized by the
total variation of the gene, and the ordinate is the logarithm of the P-value. The nominal P-value that corresponded to a FDR of 5% is stated. The
results are shown for the TNF (A) and PL (B) factors.
doi:10.1371/journal.pone.0019651.g002
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When gene lists obtained with the t test were compared to those
obtained with other methods, t-test exhibited 91% agreement (29
out of 32) with ANOVA, and 100% agreement with SAM (32 out
of 32). Similar results were obtained when the genes transcrip-
tionally modified by TNF and time were determined by the
different methods (supplementary Tables S2 and S3, respectively).
Overall, the different methods confirmed that the expression of a
significant number of genes was influenced by TNF, platelets or
time.
In contrast, there was no gene showing differential expression
when comparing experimental conditions with NRBC and those
with pRBC with a FDR of 5%. It should be stressed, however, that
the SAM method identified 11 genes when we applied a FDR of
35%. Interestingly, TARBP2, ALS2CL, P4HA1, KLK7, POR,
RANBP9, Q9H693, and SCARB1 that were identified by SAM
were also differentially expressed as determined by ANOVA with
a nominal threshold of P,0.01. Besides, we assumed that the
effect of pRBC per se was sub-optimal, and that it could be
detectable when accounting for putative interaction with TNF
and/or PL. We found evidence of an interaction between gene,
pRBC, TNF and time (P=0.02) and between gene, pRBC, PL
and time (P=0.002) by using the global GeneANOVA (Table 2).
This indicates that the effect of the interactions between pRBC
and TNF and between pRBC and PL depended on time.
Therefore, we separately analyzed gene expression at time 0 h
and 5 h, performed a two-way ANOVA, and applied a FDR of
5% to identify genes involved. There was a significant interaction
between pRBC and TNF at time 5 h for 4 genes (KTN1, RRBP1,
GLIPR1, CORO2B) and a significant interaction between pRBC
and PL for 4 genes at time 0 h (ADAMTS16, RREB1, EFNB3,
PLXDC1), and for 3 genes at time 5 h (ASB12, AP3M2, LAMP1).
This suggests that pRBC act in interaction with PL and TNF to
induce a transcriptional response in HBEC.
The Gene Ontology (GO) terms and KEGG annotations of
genes included in the different lists were analyzed by using
DAVID tools. Table 4 shows the results of the functional
annotation analysis. There was an over-representation of GO
terms, such as ‘‘immune response’’, ‘‘cell adhesion’’ and
‘‘apoptosis’’ in the list of genes regulated by TNF. The analysis
of GO terms of genes regulated by PL showed an over-
representation of ‘‘apoptosis’’ and ‘‘cytokine activity’’. The analysis
of GO terms of the 469 genes identified by the one-way ANOVA
yielded similar results (data not shown).
Table 3. List of genes transcriptionally altered by platelets.
Gene SAM
a t-test GeneAnova % variance
b
ADAM21 ++ + 65,7
ADAM28 ++ + 23,9
ANGPTL4 ++ + 31,8
BCL3 ++ + 24,4
BIRC2 + 17,4
BSCL2 ++
CCL2 ++ + 17,5
CCL4 +
CCL7 +
CCR7 ++ + 19.5
CD83 + (+)
CIRH1A ++ 17.4
COPS7B + 16.9
CSEN + (+) + 17.1
CTGF + (+)
CXCL1 ++ + 21
CXCL3 ++ + 49.6
D2S448 ++ + 16.6
DDIT4 ++ 18.3
DNASE1L3 ++ + 18.2
DUSP5 ++ 8.7
EHD1 ++ + 40.6
EPHA2 + (+)
FAM19A4 ++ + 24.5
FCER1G + (+)
FOSB + (+)
GLB1 ++ + 17.4
H1FX +
HBEGF ++ + 24.5
ID3 + (+)
IER3 ++ + 81.7
IL11 ++ + 23.2
INHBA ++ + 52.2
INHBB ++ + 33.7
IRF1 ++ + 30.6
KCNK3 ++ + 40.2
MSC ++ + 39.6
MUC4 + (+) + 25.9
NFKBIA ++ + 66.7
ODC1 +
PAK1IP1 + (+) + 15.4
PDE1A ++ + 34.2
PDE7B +
PGCP ++ + 18.3
PLK2 ++ + 34
PSFL + 17.5
PTK6 ++ + 32.3
RAVER1 + (+)
SACS ++
SLAMF8 ++ + 71.4
Gene SAM
a t-test GeneAnova % variance
b
SORL1 + (+) + 20.2
STK23 ++ + 44.3
TCEAL8
TNNI3 ++
TPD52L1 ++ + 17.8
TRAF4 +
UAP1 +
UCK2 +
+: informative genes with a FDR 5%.
(+): informative genes with a t-test 5% FDR 10%.
aSignificance Analysis of Microarray.
bpercentage of variance due to PL from multi-way ANOVA analysis.
doi:10.1371/journal.pone.0019651.t003
Table 3. Cont.
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PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e19651We used IPA software to visualize differentially expressed genes
in networks of interacting genes and to identify the biological
functions that werethe most significant in our data set. We observed
that 56 of the 58 genes differentially expressed between experi-
mental conditions with and without PL could be assigned to one
among five related networks at the 0.001 significance level (Table
S4). The analysis of the canonical pathways indicated that HBEC
has altered activities of several functional pathways, including
cytokine-, chemokine-, death receptor-, apoptosis-, erythropoietin-,
and TGFb- signaling(Table S5). Figure 5 shows the mostsignificant
network, the top functions of which were haematological system
development and immune system. We identified, in this network,
several canonical pathways significantly represented; these included
several cytokine- and chemokine- signaling pathways, but also
glucocorticoid receptor-, PPAR- and TREM1-signaling pathways.
We further analyzed the expression of 11 selected genes by RT-
qPCR to confirm their gene expression pattern. Transcript levels
for each of the 11 genes were quantified by using SYBR Green
technology. Figure 6A shows differences in their expression i)
between endothelial cells incubated with TNF and those incubated
without TNF and ii) between endothelial cells cocultured with PL
and those incubated without PL. Microarray and RT-qPCR
results were consistent, except for CCR7. Most importantly, the
positive or negative changes of expression remained consistent. As
expected, there was a difference of sensitivity between microarray
and RT-qPCR methods. RT-qPCR results of selected genes
ranged from 1.5-fold to 36-fold regulation (Figure 6A), whereas
microarray results ranged from 1.5-fold to 10-fold regulation for
the same genes (Figure 6B). The fold changes in transcript
abundance of CCR7 strongly differed between RT-qPCR and
Figure 3. Hierarchical clustering of TNF-induced genes. Hundred and seven TNF-induced genes were selected on the basis of a Welch t-test
and a FDR of 5%. The samples obtained from HBEC stimulated with TNF were compared with those from HBEC incubated without TNF. The presence
(black) and the absence (white) of TNF are shown. Genes marked with an asterisk were validated by RT-qPCR.
doi:10.1371/journal.pone.0019651.g003
Figure 4. Hierarchical clustering of platelet-induced genes. A Welch t-test and a FDR of 5% led to identify 32 PL-induced genes. The samples
obtained from HBEC co-cultured with PL were compared with those from HBEC incubated without PL. The presence (black) and the absence (white)
of PL are shown. Genes marked with an asterisk were validated by RT-qPCR.
doi:10.1371/journal.pone.0019651.g004
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ones among those for the 10 selected genes by using RT-qPCR,
and very low signal intensities were measured for CCR7 by using
the microarray technology; this indicates that differences in gene
expression are more difficult to quantify by using microarray
technology for low transcript levels.
Discussion
Here we have investigated the respective effects of TNF, PL and
pRBC on human brain endothelial cells by profiling gene
expression from in vitro co-cultures. Unsupervised hierarchical
clustering of samples indicated an effect of a short exposure to PL,
besides a strong effect of a prolonged exposure to TNF. We
applied stringent statistical analyses to identify genes differentially
expressed between the experimental conditions, and we searched
for over-representation of functional annotations to identify
pathways involved.
As expected, TNF regulated the expression of genes involved in
inflammation, such as IL32, IL11, CCL18, CXCL10, CCL2, and
CCL5, and apoptosis, such as SERPINB2, TNFSF13B and
TNFSF10. Similar results have been previously obtained with
non-cerebral endothelial cells [8,31,32,33]. Overall, our results
confirm that endothelial cells activated by TNF contribute to
endothelial cell apoptosis and leukocyte chemotaxis and activation.
Interestingly, we detected a significant down-regulation of LRPAP1
and LRP1 in TNF-stimulated HBEC. LRP1 that binds to LRPAP1
has been shown to be involved in the clearance of the b-amyloid
protein [34], which accumulates in the brain of patients with
Alzheimer’s disease [35]. Since the b-amyloid protein has been
also detected in brains during human and mouse CM [36,37], our
results suggest that TNF inhibits the capacity of HBEC to
eliminate the b-amyloid protein from brain. This further supports
the hypothesis that CM and Alzheimer’ disease share some
common mechanisms of pathogenesis [37].
Here we show that platelets dramatically modulate the
expression of genes involved in inflammation and apoptosis. The
analysis of canonical pathways revealed the effect of PL on
cytokine-, chemokine-, TGFb-, death-receptor-, apoptosis-, eryth-
ropoietin-, and TREM1-signaling. These observations are in line
with evidence that i) TGFb participates in HBEC apoptosis
induced by PL [38], ii) erythropoietin promotes endothelial cell
integrity and angiogenesis [39] and has been associated with
resistance against CM in humans and mice [40,41], iii) TREM-1,
which is expressed on myeloid and endothelial cells, has been
shown to be involved in the innate inflammatory response and
sepsis [42,43], and its ligand is expressed on human PL [44]. All
together, these data support the hypothesis that PL induce HBEC
gene expression changes affecting the outcome of malaria
infection. It should be stressed that we used platelets from one
single donor, and that this is a limitation in our approach.
However, those platelets did not show any abnormalities in term of
reactivity and probably induced a typical response of HBEC.
It is likely that both TNF and PL can contribute to apoptosis
and inflammation, suggesting that TNF and platelets work in
synergy, contributing to the same cell response. Indeed the
expression of some genes, including ADAM28, DNASEIL3, and
CCL2, appeared to be regulated both by TNF and platelets, and
the expression of other genes (GPR83, IER3, RAB4, and HLA-
DRB1) was altered by an interaction between TNF and PL. This
Table 4. Functional annotation clustering of genes differentially expressed in the presence of TNF, platelets, and between 0 h and
5 h of incubation.
Functional annotation (GO terms) % of genes P-value
TNF-regulated genes
a:
164 genes annotated/185 genes
immune response 16 6610
26b
plasma membrane 29 9610
24b
localization 29 7610
23
cell adhesion 10 3610
22
regulation of signal transduction 8 4610
22
apoptosis 11 5610
22
protein kinase cascade 7 5610
22
PL-regulated genes
a:
53 genes annotated/58 genes
cytokine activity 15 2610
25b
apoptosis 25 2610
24b
I-kappaB kinase/NF-kappaB cascade 8 2610
22
B-cell activation 6 3610
22
heparin binding 6 3610
22
Time-regulated genes
a:
136 genes annotated/158 genes
protein kinase cascade 10 1610
23b
response to biotic stimulus 6 2610
22
intracellular 74 3610
22
enzyme linked receptor protein signaling 6 3610
22
cell maturation 3 3610
22
JNK cascade 3 4610
22
aInformative genes identified by either paired t-test, paired SAM or ANOVA analyses.
bFDR,5%.
doi:10.1371/journal.pone.0019651.t004
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adherence to cerebrovascular endothelium, notably via the
overexpression of ICAM-1 on EC surface [45] and confirms that
PL potentiate the pro-apoptotic effect of TNF on HBEC [7].
Interestingly, TNF and PL also induced the expression of genes
with an anti-inflammatory and/or anti-apoptotic activity, such as
IL11 and INHBA. It should be stressed that we analyzed gene
expression immediately and 5 hours after co-cultures, whereas
apoptosis was detected in endothelial cells only 48 h after platelets
co-incubation [7]. Chakravorty et al recently proposed that the
balance between positive and negative regulation will determine
endothelial pathology during malaria infection [12]. Our result
highlights that a pro-apoptotic stimulus also induces regulatory
genes, and fits well with the observation of a transient dysfunction
of the blood brain barrier in human severe malaria [46].
When compared to previous reports [10,12,13,14], we found
that the likelihood of pRBC-induced transcriptional changes were
much lower than those triggered by PL or TNF, i.e. required a
FDR of 35% instead of 5%. Such discrepancies may reflect
differences in endothelial cell lines, in the durations of exposure to
pRBC, and in parasite strains. For instance, we co-cultured HBEC
and P. falciparum from the IPPAM strain with a polymorphic
adhesion phenotype, equally CD36- and ICAM-1-binding,
whereas others incubated endothelial cells (HUVEC, HLEC,
HBEC…) with P. falciparum ItG and ITO4-A4 (ICAM-1 binding)
or 3D7 and FCR3 (CD36-binding) strains. In addition, we co-
cultured HBEC and pRBC for a short time to detect early events,
whereas others detected transcriptional changes after a prolonged
co-culture, which may favour the effect of pRBC on endothelial
cells [10,12,13,14]. We assume that our system was not optimal to
detect the effect of pRBC per se, but might be more relevant
physiologically to analyse the early effect of adherent pRBC.
Besides, we cannot exclude that we missed some genes of interest
that were not spotted on the microarrays. Interestingly, Viebig
et al., Pino et al., Tripathi et al., and Chakravorty et al. collectively
provided evidence that pRBC represent a pro-inflammatory (cell
adhesion molecules, chemotaxis and chemokine) and a pro-
apoptotic stimulus for endothelial cells [10,12,13,14]. This suggests
Figure 5. A gene network of platelet-regulated genes. This network is the most significative network among five significative networks
obtained using the 58 PL-regulated genes with IPA (supplementary data). Twenty genes of this network are differentially expressed in HBEC in
presence of PL (colored in green for the down-regulated gene and red for up-regulated genes). The molecules hedged in orange belong to the main
canonical pathways linked to this network (Acute phase response-, B cell receptor-, Chemokine-, Erythropoietin-, Glucocorticoid receptor-, IL6-, IL8-,
IL10-, IL12-, PPAR-, RAR-, TREM-1-signaling, IRF, LXR/RXR, PPARa/RXRa, RAR activation, Role of pattern recognition receptor, Role of PKR in IFN
induction, Hepatic cholestasis, Hepatic fibrosis).
doi:10.1371/journal.pone.0019651.g005
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endothelial responses. Using a global ANOVA, we observed a
time-dependent interaction between pRBC and TNF and between
pRBC and PL, and we further identified some genes by using a
two-way ANOVA, whose expression was influenced by these high-
order interaction terms. Although the power may be insufficient to
identify such genes in our analysis, our results suggest that pRBC
together with TNF or PL contribute to endothelial responses.
In conclusion, this study shows that both TNF and PL
dramatically alter gene expression levels in HBEC, and suggests
that pRBC act in interaction with TNF and PL to induce
transcriptional changes in HBEC. It also indicates that TNF and
PL contribute to HBEC apoptosis. This study further supports the
pathogenic role of platelets, and points out several altered canonical
pathways, such as chemokine-, TGFb-, death-receptor, erythropoi-
etin-, and TREM1-signaling. We speculate that these observations
can be used to develop novel strategies to prevent CM.
Supporting Information
Figure S1 Gene expression variance analysis for time
(A) and RBC (B) factors. Each gene was plotted as a point. The
abscissa is the variation due to the factor normalized by the total
variation of the gene, and the ordinate is the logarithm of the P-value.
(DOC)
Table S1 Primers used for the RT-qPCR.
(DOC)
Table S2 List of genes transcriptionally altered by TNF.
(DOC)
Table S3 List of genes transcriptionally altered by time.
(DOC)
Table S4 IPA Network analysis based on the 58 platelet-
regulated genes.
(DOC)
Figure 6. Comparison of the expression of selected genes assessed by RT-qPCR and by microarray technology. Five TNF-induced
genes and 6 PL-induced genes were selected from the list of genes identified through Welch t-tests and multiple test corrections. For 2 genes (CCL2
and IL11), gene expression was regulated by TNF and PL. HBEC were co-cultured with NRBC in the presence or the absence of either TNF or PL to
measure the expression of TNF- or PL-specific genes, respectively. A) Gene expression was assessed by RT-qPCR. Data were analyzed by the 2
2DDC(t)
method with ACTB as a control gene. The n-fold value represents the mean of TNF- and PL-induced expression levels compared with control
conditions. Error bar represents SD between duplicates. B) Gene expression was assessed by microarray technology. The n-fold value was calculated
on the basis of normalized data when comparing the levels of TNF- and PL-induced expression with those of control conditions. Error bar represents
SD between triplicates.
doi:10.1371/journal.pone.0019651.g006
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